MIRA INFORM REPORT

 

 

Report No. :

306885

Report Date :

13.02.2015

 

IDENTIFICATION DETAILS

 

Name :

SINOPIA S.A.

 

 

Registered Office :

Carretera Al Pacifico Kilometro 19.3 Granjas Italis No.5, Villa Nueva Guatemala C A, Guatemala

 

 

Country :

Guatemala

 

 

Date of Incorporation :

07.02.2007

 

 

Legal Form :

Sociedad Anonima

 

 

Line of Business :

Import and Distribution of Pharmaceuticals Products

 

 

No. of Employees :

7

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

Guatemala

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

GUATEMALA - ECONOMIC OVERVIEW

 

Guatemala is the most populous country in Central America with a GDP per capita roughly one-half that of the average for Latin America and the Caribbean. The agricultural sector accounts for 13.5% of GDP and 30% of the labor force; key agricultural exports include coffee, sugar, bananas, and vegetables. The 1996 peace accords, which ended 36 years of civil war, removed a major obstacle to foreign investment, and since then Guatemala has pursued important reforms and macroeconomic stabilization. The Dominican Republic-Central America Free Trade Agreement (CAFTA-DR) entered into force in July 2006, spurring increased investment and diversification of exports, with the largest increases in ethanol and non-traditional agricultural exports. While CAFTA-DR has helped improve the investment climate, concerns over security, the lack of skilled workers, and poor infrastructure continue to hamper foreign direct investment. The distribution of income remains highly unequal with the richest 20% of the population accounting for more than 51% of Guatemala's overall consumption. More than half of the population is below the national poverty line, and 13% of the population lives in extreme poverty. Poverty among indigenous groups, which make up more than 40% of the population, averages 73%, with 22% of the indigenous population living in extreme poverty. Nearly one-half of Guatemala's children under age five are chronically malnourished, one of the highest malnutrition rates in the world. Guatemala is the top remittance recipient in Central America as a result of Guatemala's large expatriate community in the United States. These inflows are a primary source of foreign income, equivalent to one-half of the country's exports or one-tenth of its GDP.

 

Source : CIA

 

 

 

 

 

Company Name and Summary

 

Legal Name:

SINOPIA S.A.

Trade Name:

Sinopia 

NIT:

5214938-2

Date Created:

07.feb.2007

Date Incorporated:

2007

Legal Address:

CARRETERA AL PACIFICO KILOMETRO 19.3 GRANJAS ITALIA NO.5, VILLA NUEVA, GUATEMALA C.A.

Operative Address:

CARRETERA AL PACIFICO KILOMETRO 19.3 GRANJAS ITALIA NO.5, VILLA NUEVA, GUATEMALA C.A.

Telephone:

502 + 663 05 353

Fax:

502 + 663 07 381

Legal Form:

Sociedad Anónima

Email:

NA

Registered in:

Guatemala

Website:

No website

Manager:

Mr. Marin Mencos

Staff:

7

Activity:

Pharmaceutical Wholesale

 

BANKS

 

Banco De Guatemala

 

The company does not make its banking details public

 

 

HISTORY

 

The company was founded in 2007

 

 

 

 

PRINCIPAL ACTIVITY

 

The company is dedicated to the import and distribution of pharmaceutical products.

Products/Services description:

Pharmaceutical Products

Brands:

NA

Sales are:

Wholesale

Clients:

Pharmacies

Suppliers:

NITIKA PHARMACEUTICAL SPECIALITIES PVT. LTD.
India

Gennex Laboratories Ltd.
India

MACCO ORGANIQUES, S.R.O.
Zech Republic

Operations area:

National

The company imports from

India, China, Zech Republic

The company exports to

No exports

The subject employs

7 employees

Payments:

Regular

 

 

LOCATION

 

Headquarters :

CARRETERA AL PACIFICO KILOMETRO 19.3 GRANJAS ITALIA NO.5, VILLA NUEVA, GUATEMALA C.A.

Branches:

The company does not have branches

Industry:

 Companies in this industry serve as wholesale distributors of drugs and other pharmaceutical products. 

 

Demand for pharmaceutical distribution is driven by the need to treat illness and disease. The profitability of individual companies is determined by the efficient distribution of a wide variety of drugs and medications. Large companies compete intensely on price, size of generic drug portfolio, product volume and variety, and the quality of value-added support services such as supply chain management. Small companies can compete by focusing on rural areas, independent community pharmacies, or the distribution of drugs that have special handling requirements.

 

Major products include branded and generic prescription drugs, which account for about 75 percent of industry revenue. Other products include over-the-counter (OTC) medications, personal care products, vitamins, veterinary medicines, and surgical and medical supplies and equipment. Distributors generally act as intermediaries in the ordering and delivery of pharmaceuticals and related products obtained from manufacturers. Because the drug manufacturing industry is highly concentrated, some distributors may purchase inventory from a fairly small number of suppliers.

 

 

GROUP STRUCTURE AND SUBSIDIARY COMPANIES

 

Listed at the stock exchange:

NO

Capital:

NA

Shareholders %:

This is a private company. Depsite our long search, we could not confirm major holders.

Management:

Manager:  Mr. Marin Mencos
Attorney:   Heinrich Reitzel Gunther

Related Companies

No subsidiary companies

 

 

FINANCIAL INFORMATION

 

This is a private comapny which does not make its financial figures public.

 

 

2013 USD

 

Revenue

400 000

 

 

LEGAL FILINGS

 

There are no legal connected to the subject

 

 

SUMMARY

 

The company is dedicated to the import and distribution of pharmaceutical products.

It has 8 years of experience in the market. It has a small sized structure, with low commercial profile.

The company mainly imports from India and works for the national market.

The company is active and shows no negative. 

 

 

RISK INFORMATION

 

DEBTS

Controlled

PAYMENTS

Regular

CASH FLOW

Normal

STATUS

Active

 

ENTERVIEW

NAME

NA

POSITION

NA

COMMENTS

We tried to contact the company but reached the voicemail We left a message asking ti return the call.

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.62.43

UK Pound

1

Rs.95.02

Euro

1

Rs.70.63

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

NIT

 

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.